{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fpce.simplecast.com%2Fepisodes%2Ficis-for-advanced-nsclc-yu_Qj3GY","width":444,"version":"1.0","type":"rich","title":"Optimizing Immune Checkpoint Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/86952976-b928-4317-884c-2c7ba3b2ae4d/dd583c85-cf89-47aa-adda-df91f7df377e/pod451-oncology-spring-conferences-podcast-nsclc-icis.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/146dcd04-a093-4995-a8d5-c9d0d2c150ef\" height=\"200\" width=\"100%\" title=\"Optimizing Immune Checkpoint Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Learn from a leading expert about optimizing immune checkpoint inhibitors in advanced non-small-cell lung cancer (NSCLC) including individualizing therapy decisions and managing adverse events."}